FCMV
NERV icon

Foresite Capital Management VI’s Minerva Neurosciences NERV Stock Holding History

Foresite Capital Management VI’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
1,985,584
-1,016
-0.1% -$5.51K 1.72% 16
2026
Q1 		$12M Buy
+1,986,600
New +$11.4M 2.6% 9

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM

Foresite Capital Management VI's NERV Position: Q2 2026 in Review

Foresite Capital Management VI reduced its Minerva Neurosciences (NERV) stake by 0.05% in Q2 2026, selling an estimated $5.51K and leaving 1,985,584 shares worth $11M. The position accounts for 1.72% of the portfolio, ranked #16.

Foresite Capital Management VI first reported a position in NERV in Q1 2026 and has held it in 2 quarters since. The position peaked at $12M in Q1 2026. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Foresite Capital Management VI held 1,985,584 shares of Minerva Neurosciences worth $11M as of Q2 2026.
  • Foresite Capital Management VI sold 1,016 Minerva Neurosciences shares in Q2 2026, an estimated $5.51K.
  • Minerva Neurosciences made up 1.72% of Foresite Capital Management VI's portfolio in Q2 2026, its #16 holding.
  • Foresite Capital Management VI first reported a position in Minerva Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • Foresite Capital Management VI's Minerva Neurosciences position peaked at $12M in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Foresite Capital Management VI's 13F filing for Q2 2026, filed 14 Aug 2026.